Kumarasamy Jayakanthan

Kumarasamy Jayakanthan

Auto-generated profile, based on publicly available information

Kumarasamy Jayakanthan

Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, Canada V5A 1S6

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2009 in Biochemistry
Verified
Journal Article
Closed access
LSLyann Sim
Lyann Sim
KJKumarasamy Jayakanthan
Kumarasamy Jayakanthan
SMSankar Mohan
Sankar Mohan
RNRavindranath Nasi
Ravindranath Nasi
BJBlair D. Johnston
Blair D. Johnston
DRDavid R. Rose
David R. Rose

30 March 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KJKumarasamy Jayakanthan
Kumarasamy Jayakanthan
SMSankar Mohan
Sankar Mohan
BPB. Mario Pinto
B. Mario Pinto

1 July 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KJKyra Jones
Kyra Jones
LSLyann Sim
Lyann Sim
SMSankar Mohan
Sankar Mohan
JKJayakanthan Kumarasamy
Jayakanthan Kumarasamy
HLHui Liu
Hui Liu
DRDavid R. Rose
David R. Rose

1 November 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WZWesley F. Zandberg
Wesley F. Zandberg
JKJayakanthan Kumarasamy
Jayakanthan Kumarasamy
BPB. Mario Pinto
B. Mario Pinto
DVDavid J. Vocadlo
David J. Vocadlo
Sialyl-Lewis X (sLeX) is a tetrasaccharide that serves as a ligand for the set of cell adhesion proteins known as selectins. This interaction enables adhesion of leukocytes and cancer cells to endothelial cells within capillaries, resulting in their extravasation into tissues. The last step in sLeX biosynthesis is the α1,3-fucosyltrasferase (FUT)-catalyzed transfer of an L-fucose residue to carbohydrate acceptors. Impairing FUT activity compromises leukocyte homing to sites of inflammation and renders cancer cells less malignant. Inhibition of FUTs is, consequently, of great interest, but efforts to generate glycosyltransferase inhibitors, including FUT inhibitors, has proven challenging. Here we describe a metabolic engineering strategy to inhibit the biosynthesis of sLeX in cancer cells using peracetylated 5-thio-L-fucose (5T-Fuc). We show that 5T-Fuc is taken up by cancer cells and then converted into a sugar nucleotide analog, GDP-5T-Fuc, that blocks FUT activity and limits sLeX presentation on HepG2 cells with an EC50 in the low micromolar range. GDP-5T-Fuc itself does not get transferred by either FUT3 or FUT7 at a measurable rate. We further demonstrate that treatment of cells with 5T-Fuc impaired their adhesive properties to immobilized adhesion molecules and human endothelial cells. 5T-Fuc, therefore, is a useful probe that can be used to modulate sLeX levels in cells to evaluate the consequences of inhibiting FUT-mediated sLeX formation. These data also reveal the utility of using sugar analogues that lead to formation of donor substrate analogues within cells as a general approach to blocking glycosyltransferases in cells.

1 January 2004 in Tetrahedron
Verified
Journal Article
Closed access
KJK Jayakanthan
K Jayakanthan
KMK.P Madhusudanan
K.P Madhusudanan
YVYashwant D Vankar
Yashwant D Vankar

1 July 2008 in Carbohydrate Research
Verified
Journal Article
Closed access
KJKumarasamy Jayakanthan
Kumarasamy Jayakanthan
BJBlair D. Johnston
Blair D. Johnston
BPB. Mario Pinto
B. Mario Pinto